drugset / Trial / NCT02554734

Pharmacokinetic Study in Healthy Volunteers

NCT02554734

Phase 1 Completed 15 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

Phase I open, randomized cross-over pharmacokinetic study.

Timeline

Start
2015-08
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown
Comparator Entacapone Small molecule
Subject Levodopa Small molecule
Subject ODM-104 Unknown

Indications